L-Tryptophan and the Eosinophilia-Myalgia Syndrome: Current Understanding of the Etiology and Pathogenesis
- 1 January 1993
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 100 (1) , S97-S105
- https://doi.org/10.1038/jid.1993.31
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndromeThe Lancet, 1991
- Peripheral neuropathy associated with eosinophilia-myalgia syndromeAnnals of Neurology, 1990
- L-Tryptophan-Associated Eosinophilic Perimyositis, Neuritis, and FasciitisMedicine, 1990
- Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndromeSeminars in Arthritis and Rheumatism, 1990
- L-Tryptophan Ingestion Associated with Eosinophilic Fasciitis but Not Progressive Systemic SclerosisAnnals of Internal Medicine, 1990
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Tryptophan-Associated Eosinophilic Connective-Tissue DiseaseJAMA, 1990
- Development of Diffuse Fasciitis with Eosinophilia during L-Tryptophan Treatment: Demonstration of Elevated Type I Collagen Gene Expression in Affected TissuesAnnals of Internal Medicine, 1990
- Clinical Epidemiology of Toxic-Oil SyndromeNew England Journal of Medicine, 1983